Oklahoma Medical Cannabis Cultivation License Reinstated
An administrative law judge in Oklahoma has ruled in favor of Cedric Gardens Inc., a state-licensed medical cannabis cultivator, allowing the company to resume business operations. This decision overturns an emergency suspension order issued by the Oklahoma Medical Marijuana Authority (OMMA) on February 24, 2026, which had halted the operations of one of the state’s largest outdoor cannabis farms. The reinstatement of the medical cannabis cultivation license underscores the ongoing legal and regulatory complexities within Oklahoma’s burgeoning medical cannabis market.
The OMMA’s initial suspension alleged that regulators discovered more than 1,923 pounds of cannabis flower and 5,742 pounds of shake that were deemed “untagged” and “unreconcilable” within Metrc, the state’s mandated seed-to-sale tracking system. Such discrepancies in tracking systems are often a significant concern for regulators, as they can indicate potential diversion or lack of oversight in the supply chain.
Regulatory Allegations and Company Defense
Cedric Gardens Inc. contested the OMMA’s findings, asserting that the product in question was fully compliant with state law. According to attorney Dana L. Kurtz of Wirth Law Office, representing Cedric Gardens, officials did not conduct a proper investigation into their findings. Kurtz stated, as reported by Ganjapreneur, that the defense successfully demonstrated:
- There was no public safety threat posed by the product.
- Cedric Gardens’ business practices had received annual approval from OMMA without prior citations or disciplinary actions.
- All product was fully reconcilable within the Metrc system, a fact Kurtz claimed OMMA failed to verify before issuing the suspension.
Susan Brosky, co-owner of Cedric Gardens, expressed satisfaction with the ruling, reiterating the company’s commitment to public safety. She affirmed that the company has “never provided product to the public that posed a public safety risk,” according to the Ganjapreneur report.
Broader Industry Context and Political Climate
This ruling comes amidst a period of heightened scrutiny and political debate surrounding Oklahoma’s medical cannabis industry. Earlier in February, Governor Kevin Stitt (R) publicly stated that the state’s medical cannabis program represents “one of the greatest threats to public safety” in Oklahoma, suggesting that voters should consider repealing the program. This sentiment reflects ongoing concerns among some state officials regarding regulatory enforcement and the rapid expansion of the industry.
The OMMA, which oversees the state’s medical cannabis program, has been actively involved in various enforcement actions, including license suspensions and product recalls, as previously reported by Hemp Gazette. The administrative judge’s decision in the Cedric Gardens case highlights the legal avenues available to licensed operators challenging regulatory actions and the importance of thorough investigation and evidence in such disputes. For investors and operators, this case provides a critical reminder of the dynamic regulatory landscape and the potential for legal challenges to impact business continuity.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.
